
Accuray (ARAY) Stock Forecast & Price Target
Accuray (ARAY) Analyst Ratings
Bulls say
Accuray is showing strong signs of organic growth as seen through higher than expected product revenue, improved product reliability, and increased service revenue. With its advanced technology, the company is well positioned to capture a greater market share in the spheric radiation therapy market, despite facing challenges such as geopolitical tensions and US-China tariffs.
Bears say
Accuray is facing several headwinds including geopolitical tensions, order volume, and the ability to convert orders to revenue. Despite cost-cutting efforts, they are struggling to achieve consistent revenue growth and profitability, and have recently lowered their guidance due to continued volatility and tariffs in China. As such, a Neutral rating is justified as there may not be a clear path to improvement in the near future.
This aggregate rating is based on analysts' research of Accuray and is not a guaranteed prediction by Public.com or investment advice.
Accuray (ARAY) Analyst Forecast & Price Prediction
Start investing in Accuray (ARAY)
Order type
Buy in
Order amount
Est. shares
0 shares